The implication of this anti-NA Abs response in terms of serological protection against the influenza virus cannot be evaluated using the methodology used, so it is necessary to conduct studies in vivo to determine the effectiveness of a hypothetical influenza vaccine that contains a standardized amount of NA. The gene discussed is XK; the disease is influenza.